NextCure Inc.
NXTC | NASDAQ
$6.31
-$0.22 (-3.30%)
At close: Oct 30, 2026, 4:00 PM ET
$6.18
-$0.13 (-2.06%)
After-hours:
Oct 30, 2026, 7:35 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 22.38M |
Cost of Revenue | 2.19M | n/a | n/a | n/a | n/a | 46.55M |
Gross Profit | -2.19M | n/a | n/a | n/a | n/a | -24.18M |
Operating Income | -57.62M | -59.75M | -67.64M | -75.91M | -70.77M | -41.23M |
Interest Income | n/a | n/a | n/a | 1.17M | 1.32K | 4.55K |
Pretax Income | -55.84M | -55.65M | -62.72M | -74.73M | -69.39M | -36.6M |
Net Income | -55.84M | -55.65M | -62.72M | -74.73M | -69.39M | -36.6M |
Selling & General & Admin | 12.69M | 15.72M | 19.71M | 21.71M | 20.57M | 17.05M |
Research & Development | 44.92M | 41.49M | 47.93M | 54.2M | 50.19M | 46.55M |
Other Expenses | -2.19M | 2.54M | n/a | n/a | n/a | -46.55M |
Operating Expenses | 55.43M | 59.75M | 67.64M | 75.91M | 70.77M | 17.05M |
Interest Expense | n/a | n/a | n/a | n/a | 77K | 183K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 57.62M | 59.75M | 67.64M | 75.91M | 70.77M | 63.6M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.84M | 2.33M | 2.32M | 2.31M | 2.3M | 2.29M |
Shares Outstanding (Diluted) | 2.84M | 2.33M | 2.32M | 2.31M | 2.3M | 2.29M |
EPS (Basic) | -19.65 | -23.88 | -27.04 | -32.32 | -30.15 | -15.95 |
EPS (Diluted) | -19.65 | -23.88 | -27.04 | -32.32 | -30.15 | -15.95 |
EBITDA | -53.66M | -54.34M | -59.04M | -70.61M | -65.14M | -37.81M |
EBIT | -55.84M | -57.21M | -62.72M | -74.73M | -69.31M | -41.23M |
Depreciation & Amortization | 2.19M | 2.87M | 3.68M | 4.12M | 4.18M | 3.41M |
Add to Watchlist
Select watchlists to add or remove NXTC